Skip to content
healthcare.dev

BRILINTA

NDC 71610-815, Ticagrelor, tablet, from Aphena Pharma Solutions - Tennessee, LLC.

Product NDC
71610-815
Status
Listed
Labeler
Aphena Pharma Solutions - Tennessee, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA022433
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71610-815 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TICAGRELOR90 mg/1

Pharmacologic classes

Cytochrome P450 3A4 Inhibitors [MoA]; Decreased Platelet Aggregation [PE]; P-Glycoprotein Inhibitors [MoA]; P2Y12 Platelet Inhibitor [EPC]; P2Y12 Receptor Antagonists [MoA]

Package NDCNDC-11Package
71610-815-41716100815415400 TABLET in 1 BOTTLE (71610-815-41)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/1547e2b6-8858-178e-e063-6394a90abb23

Use it

Look up 71610-815 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71610-815 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71610-815. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.